SEC Form 4 · accession 0001127602-16-046249

THERMO FISHER SCIENTIFIC INC. · TMO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive Vice President

Period of report

Mar 10, 2016

Accepted (ET)

Mar 14, 2016 · 4:47 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000097745

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 10, 2016	M	17,850	$124.28	A	65,136	D
Common Stock	Mar 10, 2016	M	8,075	$131.07	A	73,211	D
Common Stock^F1	Mar 10, 2016	S	9,525	$139.56	D	63,686	D
Common Stock^F2	Mar 10, 2016	S	16,400	$138.75	D	47,286	D
Common Stock	holding	—	—		—	14,256	I	By Spouse

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$124.28	Mar 10, 2016	M	17,850	D	—	Feb 26, 2021	Common Stock	17,850	17,850	D
Stock Option (Right to Buy)^F4	$131.07	Mar 10, 2016	M	8,075	D	—	Feb 25, 2022	Common Stock	8,075	24,225	D

F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.10 to $140.04, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.18 to $139.09, inclusive.
F3The option vests in four equal annual installments beginning on February 26, 2015.
F4The option vests in four equal annual installments beginning on February 25, 2016.